Answers are grounded in this paper and cite their sources.
Characterizing microRNA transcriptional regulation is challenging because primary microRNA transcripts undergo rapid nuclear processing, leaving full-length molecules poorly represented in conventional transcriptomic data. DIANA-miRGen v5 addresses this annotation gap by combining Capture Long-read Sequencing (CLS) data, generated within GENCODE to improve non-coding RNA annotation, with GENCODE reference gene and transcript annotations to resolve miRNA host contexts. For human, the database provides experimentally informed, transcript-anchored host and promoter annotations for 1560/1918 pre-miRNA loci (81.3%), represented by 1302 distinct reference transcripts. CLS-derived human transcription start sites (TSSs) are accompanied by overlap information from FANTOM5 CAGE, ENCODE PRO-cap, and RAMPAGE. Transcription factor (TF)-filtered ChIP-Atlas data annotate candidate TF occupancy within windows extending 10 kb upstream and 2 kb downstream of selected host TSSs, yielding 4 901 330 human gene-level host-window overlap records. For mouse, annotations cover 994/1227 loci (81.0%), comprising 785 distinct reference transcripts. Mouse TSSs obtained from CLS include FANTOM5 CAGE overlap information, while ChIP-Atlas analysis yielded 2 378 918 gene-level host-window overlap records. The redesigned interface supports linked gene- and transcript-level exploration, interactive genome visualization, contextual tracks, bulk downloads, and open access through a REST API. DIANA-miRGen v5 is freely available without registration at http://microrna.gr/mirgenv5/.
No takes yet. Share an insight, caveat, or question.
Giannoukakos et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: